Cargando…
mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors
CD11b(+) Gr1(+) myeloid-derived suppressor cells (MDSCs) play critical roles in controlling the processes of tumors, infections, autoimmunity and graft rejection. Immunosuppressive drug rapamycin (RPM), targeting on the key cellular metabolism molecule mTOR, is currently used in clinics to treat pat...
Autores principales: | Wu, Tingting, Zhao, Yang, Wang, Hao, Li, yang, Shao, Lijuan, Wang, Ruoyu, Lu, Jun, Yang, Zhongzhou, Wang, Junjie, Zhao, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735296/ https://www.ncbi.nlm.nih.gov/pubmed/26833095 http://dx.doi.org/10.1038/srep20250 |
Ejemplares similares
-
The mTOR Deficiency in Monocytic Myeloid-Derived Suppressor Cells Protects Mouse Cardiac Allografts by Inducing Allograft Tolerance
por: Li, Jiawei, et al.
Publicado: (2021) -
Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017) -
The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury
por: Zhang, Chao, et al.
Publicado: (2017) -
Oncogenic mTOR signaling recruits myeloid-derived suppressor cells to promote tumor initiation
por: Welte, Thomas, et al.
Publicado: (2016) -
TOX Acts as a Tumor Suppressor by Inhibiting mTOR Signaling in Colorectal Cancer
por: Yang, Mengdi, et al.
Publicado: (2021)